Corona Remedies Limited is launching its Initial Public Offering (IPO) to raise funds through a book-built offer. The IPO comprises a pure offer for the sale of 0.62 crore equity shares aggregating up to Rs. 655.37 crore. There is no fresh issue component in this IPO.

Corona Remedies Limited’s IPO price band is set at Rs. 1,008 to Rs. 1,062 per share. The IPO opens for subscription on December 8, 2025, and closes on December 10, 2025. The shares will be listed on NSE and BSE on Monday, December 15, 2025. Here’s everything you need to know.

GMP of Corona Remedies Limited IPO

As of December 8th, 2025, the shares of Corona Remedies Limited in the grey market were trading at a 27.31 percent premium. The shares in the Grey Market traded at Rs. 1,352. This gives it a premium of Rs. 290 per sh

See Full Page